Substrates for peptidase S01.005: mast cell peptidase 4 (Rattus)
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coagulation factor V | P12259 | 2015-2020 | Val-Met-Tyr-Phe2018+Asn-Gly | N | CS | Val | Met | Tyr | Phe | Asn | Gly | - | - | Karlson et al., 2002 | ||
| Cysteine-rich secretory protein 3 | P54108 | 142-147 | Val-Val-Trp-Tyr145+Ser-Ser | N | CS | Val | Val | Trp | Tyr | Ser | Ser | - | - | Karlson et al., 2002 | ||
| Leu-Val-Trp-Phe-Arg-Gly | Leu-Val-Trp-Phe+Arg-Gly | N | Leu | Val | Trp | Phe | Arg | Gly | - | - | Karlson et al., 2002 | |||||
| Low affinity immunoglobulin gamma Fc region receptor III | P27645 | 216-221 | Leu-Val-Trp-Phe219+His-Ala | P | CS | Leu | Val | Trp | Phe | His | Ala | - | - | Karlson et al., 2002 | ||
| MeoSuc-Arg-Ala-Tyr-NHPhNO2 | MeoSuc-Arg-Ala-Tyr+NHPhNO2 | S | MSu | Arg | Ala | Tyr | NAN | - | - | - | Karlson et al., 2002 | |||||
| Plasminogen activator inhibitor 1 | P20961 | 191-196 | Ala-Leu-Tyr-Phe194+Asn-Gly | P | CS | Ala | Leu | Tyr | Phe | Asn | Gly | - | - | Karlson et al., 2002 | ||
| Pro-Gly-Gly-Ala-Val-Glu-Tyr-Tyr-Arg-Phe-Asp-Ser-(His)6 | Pro-Gly-Gly-Ala-Val-Glu-Tyr-Tyr+Arg-Phe-Asp-Ser-(His)6 | N | NU | Val | Glu | Tyr | Tyr | Arg | Phe | Asp | Ser | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Arg-Trp-Met-Leu-Val-Trp-Phe-Arg-Arg-(His)6 | Pro-Gly-Gly-Arg-Trp-Met-Leu-Val-Trp-Phe+Arg-Arg-(His)6 | N | NU | Leu | Val | Trp | Phe | Arg | Arg | His | His | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Asp-Glu-Val-Val-Phe-Tyr-Leu-Gly-Phe-(His)6 | Pro-Gly-Gly-Asp-Glu-Val-Val-Phe-Tyr+Leu-Gly-Phe-(His)6 | N | NU | Val | Val | Phe | Tyr | Leu | Gly | Phe | His | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Asp-Met-Val-Trp-Leu-Met-Tyr-Arg-Leu-(His)6 | Pro-Gly-Gly-Asp-Met-Val-Trp-Leu-Met-Tyr+Arg-Leu-(His)6 | N | NU | Trp | Leu | Met | Tyr | Arg | Leu | His | His | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Glu-Leu-Val-Leu-Phe-Met-Gly-Gly-Trp-(His)6 | Pro-Gly-Gly-Glu-Leu-Val-Leu-Phe+Met-Gly-Gly-Trp-(His)6 | N | NU | Leu | Val | Leu | Phe | Met | Gly | Gly | Trp | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Glu-Trp-Met-Val-Trp-Phe-Thr-Gly-Val-(His)6 | Pro-Gly-Gly-Glu-Trp-Met-Val-Trp-Phe+Thr-Gly-Val-(His)6 | N | NU | Met | Val | Trp | Phe | Thr | Gly | Val | His | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Gly-Leu-Met-Phe-Phe-Gln-Gly-Gly-Trp-(His)6 | Pro-Gly-Gly-Gly-Leu-Met-Phe-Phe+Gln-Gly-Gly-Trp-(His)6 | N | NU | Leu | Met | Phe | Phe | Gln | Gly | Gly | Trp | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Gly-Leu-Thr-Trp-Phe-Met-Gly-Thr-Trp-(His)6 | Pro-Gly-Gly-Gly-Leu-Thr-Trp-Phe+Met-Gly-Thr-Trp-(His)6 | N | NU | Leu | Thr | Trp | Phe | Met | Gly | Thr | Trp | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Gly-Phe-Ser-Phe-Phe-Trp-Gly-Arg-Trp-(His)6 | Pro-Gly-Gly-Gly-Phe-Ser-Phe-Phe+Trp-Gly-Arg-Trp-(His)6 | N | NU | Phe | Ser | Phe | Phe | Trp | Gly | Arg | Trp | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Ile-Glu-Trp-Tyr-Ser-Gly-Arg-Leu-Trp-(His)6 | Pro-Gly-Gly-Ile-Glu-Trp-Tyr+Ser-Gly-Arg-Leu-Trp-(His)6 | N | NU | Ile | Glu | Trp | Tyr | Ser | Gly | Arg | Leu | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Ile-Ile-Trp-Tyr-Val-Ala-Leu-Pro-Glu-(His)6 | Pro-Gly-Gly-Ile-Ile-Trp-Tyr+Val-Ala-Leu-Pro-Glu-(His)6 | N | NU | Ile | Ile | Trp | Tyr | Val | Ala | Leu | Pro | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Leu-Leu-Tyr-Phe-Arg-Gly-Val-Glu-Val-(His)6 | Pro-Gly-Gly-Leu-Leu-Tyr-Phe+Arg-Gly-Val-Glu-Val-(His)6 | N | NU | Leu | Leu | Tyr | Phe | Arg | Gly | Val | Glu | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Leu-Met-Trp-Phe-Arg-Gly-Ala-Phe-Asp-(His)6 | Pro-Gly-Gly-Leu-Met-Trp-Phe+Arg-Gly-Ala-Phe-Asp-(His)6 | N | NU | Leu | Met | Trp | Phe | Arg | Gly | Ala | Phe | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Leu-Met-Trp-Phe-Arg-Gly-Leu-Ser-Ile-(His)6 | Pro-Gly-Gly-Leu-Met-Trp-Phe+Arg-Gly-Leu-Ser-Ile-(His)6 | N | NU | Leu | Met | Trp | Phe | Arg | Gly | Leu | Ser | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Leu-Val-Leu-Phe-Ala-Ser-Arg-Val-Val-(His)6 | Pro-Gly-Gly-Leu-Val-Leu-Phe+Ala-Ser-Arg-Val-Val-(His)6 | N | NU | Leu | Val | Leu | Phe | Ala | Ser | Arg | Val | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Leu-Val-Met-Phe-Ser-Gly-Thr-Tyr-Trp-(His)6 | Pro-Gly-Gly-Leu-Val-Met-Phe+Ser-Gly-Thr-Tyr-Trp-(His)6 | N | NU | Leu | Val | Met | Phe | Ser | Gly | Thr | Tyr | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Leu-Val-Trp-Tyr-Asn-Leu-Pro-Leu-Ser-(His)6 | Pro-Gly-Gly-Leu-Val-Trp-Tyr+Asn-Leu-Pro-Leu-Ser-(His)6 | N | NU | Leu | Val | Trp | Tyr | Asn | Leu | Pro | Leu | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Leu-Val-Tyr-Tyr-Val-Ser-Arg-Arg-Met-(His)6 | Pro-Gly-Gly-Leu-Val-Tyr-Tyr+Val-Ser-Arg-Arg-Met-(His)6 | N | NU | Leu | Val | Tyr | Tyr | Val | Ser | Arg | Arg | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Met-Leu-Thr-Trp-Phe-Phe-Ser-Thr-Pro-(His)6 | Pro-Gly-Gly-Met-Leu-Thr-Trp-Phe+Phe-Ser-Thr-Pro-(His)6 | N | NU | Leu | Thr | Trp | Phe | Phe | Ser | Thr | Pro | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Ser-Leu-Val-Trp-Phe-Arg-Ser-Lys-Phe-(His)6 | Pro-Gly-Gly-Ser-Leu-Val-Trp-Phe+Arg-Ser-Lys-Phe-(His)6 | N | NU | Leu | Val | Trp | Phe | Arg | Ser | Lys | Phe | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Trp-Ile-Trp-Tyr-Asn-Ser-Val-Leu-Lys-(His)6 | Pro-Gly-Gly-Trp-Ile-Trp-Tyr+Asn-Ser-Val-Leu-Lys-(His)6 | N | NU | Trp | Ile | Trp | Tyr | Asn | Ser | Val | Leu | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Trp-Leu-Phe-Phe-Asn-Gly-Ser-Leu-Trp-(His)6 | Pro-Gly-Gly-Trp-Leu-Phe-Phe+Asn-Gly-Ser-Leu-Trp-(His)6 | N | NU | Trp | Leu | Phe | Phe | Asn | Gly | Ser | Leu | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Trp-Leu-Val-Trp-Phe-Arg-Gly-Gln-Arg-(His)6 | Pro-Gly-Gly-Trp-Leu-Val-Trp-Phe+Arg-Gly-Gln-Arg-(His)6 | N | NU | Leu | Val | Trp | Phe | Arg | Gly | Gln | Arg | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Trp-Val-Phe-Phe-Gln-Ser-Ala-Leu-Pro-(His)6 | Pro-Gly-Gly-Trp-Val-Phe-Phe+Gln-Ser-Ala-Leu-Pro-(His)6 | N | NU | Trp | Val | Phe | Phe | Gln | Ser | Ala | Leu | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Trp-Val-Phe-Phe-Ser-Tyr-Ser-Glu-Leu-(His)6 | Pro-Gly-Gly-Trp-Val-Phe-Phe+Ser-Tyr-Ser-Glu-Leu-(His)6 | N | NU | Trp | Val | Phe | Phe | Ser | Tyr | Ser | Glu | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Tyr-Ile-Trp-Phe-Leu-Gly-Glu-Met-Pro-(His)6 | Pro-Gly-Gly-Tyr-Ile-Trp-Phe+Leu-Gly-Glu-Met-Pro-(His)6 | N | NU | Tyr | Ile | Trp | Phe | Leu | Gly | Glu | Met | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Tyr-Thr-Tyr-Tyr-Ser-Leu-Leu-Val-Val-(His)6 | Pro-Gly-Gly-Tyr-Thr-Tyr-Tyr+Ser-Leu-Leu-Val-Val-(His)6 | N | NU | Tyr | Thr | Tyr | Tyr | Ser | Leu | Leu | Val | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Val-Ala-Gly-Leu-Gly-Ser-Phe-Gly-His-(His)6 | Pro-Gly-Gly-Val-Ala-Gly-Leu-Gly-Ser-Phe+Gly-His-(His)6 | N | NU | Leu | Gly | Ser | Phe | Gly | His | His | His | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Val-Val-Trp-Phe-Arg-Gly-Val-Phe-Ser-(His)6 | Pro-Gly-Gly-Val-Val-Trp-Phe+Arg-Gly-Val-Phe-Ser-(His)6 | N | NU | Val | Val | Trp | Phe | Arg | Gly | Val | Phe | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Val-Val-Trp-Tyr-Ser-Leu-Val-Pro-Tyr-(His)6 | Pro-Gly-Gly-Val-Val-Trp-Tyr+Ser-Leu-Val-Pro-Tyr-(His)6 | N | NU | Val | Val | Trp | Tyr | Ser | Leu | Val | Pro | Karlson et al., 2002 | ||||
| Pro-Gly-Gly-Val-Val-Trp-Tyr-Val-Ala-Thr-Leu-Ser-(His)6 | Pro-Gly-Gly-Val-Val-Trp-Tyr+Val-Ala-Thr-Leu-Ser-(His)6 | N | NU | Val | Val | Trp | Tyr | Val | Ala | Thr | Leu | Karlson et al., 2002 | ||||
| Procollagen C-endopeptidase enhancer 1 | O08628 | 142-147 | Leu-Leu-Trp-Tyr145+Ser-Gly | P | CS | Leu | Leu | Trp | Tyr | Ser | Gly | - | - | Karlson et al., 2002 | ||
| Transforming growth factor beta receptor type 3 | P26342 | 518-523 | Val-Val-Tyr-Tyr521+Asn-Ser | N | CS | Val | Val | Tyr | Tyr | Asn | Ser | - | - | Karlson et al., 2002 | ||
| Vitamin K-dependent protein C | P31394 | 406-412 | Val-Val-Phe-Phe410+Arg-Gly | P | CS | Val | Val | Phe | Phe | Arg | Gly | - | - | Karlson et al., 2002 |
